Free Trial

kneat.com (TSE:KSI) Sets New 12-Month High - What's Next?

kneat.com logo with Medical background

kneat.com, inc. (TSE:KSI - Get Free Report) reached a new 52-week high during trading on Thursday . The stock traded as high as C$6.47 and last traded at C$6.43, with a volume of 125278 shares traded. The stock had previously closed at C$6.23.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on KSI shares. CIBC set a C$6.00 target price on shares of kneat.com and gave the company an "outperform" rating in a research note on Tuesday, October 29th. Cibc World Mkts upgraded kneat.com to a "strong-buy" rating in a report on Tuesday, October 29th.

Read Our Latest Stock Report on kneat.com

kneat.com Price Performance

The company has a market capitalization of C$552.98 million, a price-to-earnings ratio of -40.19, a PEG ratio of 597.67 and a beta of 1.08. The company has a debt-to-equity ratio of 95.14, a quick ratio of 1.50 and a current ratio of 1.47. The business's 50 day moving average is C$5.72 and its 200 day moving average is C$5.02.

kneat.com Company Profile

(Get Free Report)

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.

Recommended Stories

Should You Invest $1,000 in kneat.com Right Now?

Before you consider kneat.com, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and kneat.com wasn't on the list.

While kneat.com currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

While 2025 may not deliver massive returns, so MarketBeat analyst Chris Markoch shares his list of seven stocks primed for consistent performance.

Related Videos

The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Small Caps, Financials & Bitcoin Lead the Rising Bull Market: Chris Rowe’s Top Picks
Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines